Prostatic Neoplasms
|
0.400 |
GeneticVariation
|
group |
LHGDN |
Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
|
17932344 |
2007 |
Prostatic Neoplasms
|
0.400 |
GeneticVariation
|
group |
LHGDN |
Estrogen receptor beta polymorphism is associated with prostate cancer risk.
|
16551880 |
2006 |
Prostatic Neoplasms
|
0.400 |
GeneticVariation
|
group |
LHGDN |
Association between estrogen and androgen receptor genes and prostate cancer risk.
|
18952763 |
2009 |
Prostatic Neoplasms
|
0.400 |
GeneticVariation
|
group |
LHGDN |
Dietary intake of phytoestrogens, estrogen receptor-beta polymorphisms and the risk of prostate cancer.
|
16921512 |
2006 |
Prostatic Neoplasms
|
0.400 |
Biomarker
|
group |
CTD_human |
Dietary intake of phytoestrogens, estrogen receptor-beta polymorphisms and the risk of prostate cancer.
|
16921512 |
2006 |
Prostatic Neoplasms
|
0.400 |
Biomarker
|
group |
CTD_human |
[Implications of estrogens and their receptors for the development and progression of prostate cancer].
|
16220300 |
2005 |
Prostatic Neoplasms
|
0.400 |
Biomarker
|
group |
BEFREE |
Our results demonstrate that estrogens and antiestrogens affect prostate tumor growth through ERβ-mediated regulation of KLF5.
|
21487105 |
2011 |
Prostatic Neoplasms
|
0.400 |
Biomarker
|
group |
LHGDN |
Thus our findings implicate ERbeta as a potential target for the treatment of prostate tumours.
|
15171712 |
2004 |
Prostatic Neoplasms
|
0.400 |
Biomarker
|
group |
CTD_human |
Apigenin suppresses cancer cell growth through ERbeta.
|
17132221 |
2006 |
Prostatic Neoplasms
|
0.400 |
Biomarker
|
group |
BEFREE |
Thus our findings implicate ERbeta as a potential target for the treatment of prostate tumours.
|
15171712 |
2004 |
Prostatic Neoplasms
|
0.400 |
Biomarker
|
group |
CTD_human |
Regulation and expression of human CYP7B1 in prostate: overexpression of CYP7B1 during progression of prostatic adenocarcinoma.
|
17639508 |
2007 |
Prostatic Neoplasms
|
0.400 |
Biomarker
|
group |
CTD_human |
The evolving role of estrogen therapy in prostate cancer.
|
15046698 |
2002 |
Prostatic Neoplasms
|
0.400 |
Biomarker
|
group |
LHGDN |
Expression of estrogen receptor beta in prostate carcinoma cells inhibits invasion and proliferation and triggers apoptosis.
|
15147889 |
2004 |
Prostatic Neoplasms
|
0.400 |
Biomarker
|
group |
CTD_human |
The mRNA levels of PPFIBP2 and ESR2 are differentially expressed in prostate tumours and paired normal tissues.
|
26443449 |
2015 |
Prostatic Neoplasms
|
0.400 |
Therapeutic
|
group |
CTD_human |
[Implications of estrogens and their receptors for the development and progression of prostate cancer].
|
16220300 |
2005 |
Prostatic Neoplasms
|
0.400 |
Therapeutic
|
group |
CTD_human |
The mRNA levels of PPFIBP2 and ESR2 are differentially expressed in prostate tumours and paired normal tissues.
|
26443449 |
2015 |
Prostatic Neoplasms
|
0.400 |
Therapeutic
|
group |
CTD_human |
Apigenin suppresses cancer cell growth through ERbeta.
|
17132221 |
2006 |
Prostatic Neoplasms
|
0.400 |
Therapeutic
|
group |
CTD_human |
The evolving role of estrogen therapy in prostate cancer.
|
15046698 |
2002 |
Prostatic Neoplasms
|
0.400 |
Therapeutic
|
group |
CTD_human |
Dietary intake of phytoestrogens, estrogen receptor-beta polymorphisms and the risk of prostate cancer.
|
16921512 |
2006 |
Prostatic Neoplasms
|
0.400 |
Therapeutic
|
group |
CTD_human |
Regulation and expression of human CYP7B1 in prostate: overexpression of CYP7B1 during progression of prostatic adenocarcinoma.
|
17639508 |
2007 |
Prostatic Neoplasms
|
0.400 |
AlteredExpression
|
group |
BEFREE |
The mRNA levels of PPFIBP2 and ESR2 are differentially expressed in prostate tumours and paired normal tissues.
|
26443449 |
2015 |
Prostatic Neoplasms
|
0.400 |
AlteredExpression
|
group |
BEFREE |
Expression of Sp1 and c-FLIP are elevated while AKR1C1, ERβ and Sp3 are significantly low in human prostate tumor samples.
|
25816367 |
2015 |
Prostatic Neoplasms
|
0.400 |
AlteredExpression
|
group |
LHGDN |
Estrogen receptor beta displays cell cycle-dependent expression and regulates the G1 phase through a non-genomic mechanism in prostate carcinoma cells.
|
18607069 |
2008 |
Prostatic Neoplasms
|
0.400 |
AlteredExpression
|
group |
LHGDN |
BPA dramatically attenuated estrogen receptor beta (ERbeta) expression; this finding was specific to prostate tumor cells in which BPA induces cellular proliferation.
|
18007998 |
2007 |
Prostatic Neoplasms
|
0.400 |
AlteredExpression
|
group |
BEFREE |
An inverse correlation between the expression of ERβ and IKKβ/p65 was also observed in the prostates of ERβ knockout (BERKO) mice, Gleason grade 5 prostate tumors and analysis of prostate cancer databases.
|
26450901 |
2015 |